BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 28430601)

  • 21. p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation.
    Fahmi A; Smart N; Punn A; Jabr R; Marber M; Heads R
    Cell Signal; 2013 Apr; 25(4):898-909. PubMed ID: 23268184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
    Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
    J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells.
    Carbotti G; Nikpoor AR; Vacca P; Gangemi R; Giordano C; Campelli F; Ferrini S; Fabbi M
    J Exp Clin Cancer Res; 2017 Oct; 36(1):140. PubMed ID: 29020964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
    Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM
    Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-6, but not IFN-gamma, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing.
    Regis G; Icardi L; Conti L; Chiarle R; Piva R; Giovarelli M; Poli V; Novelli F
    Leukemia; 2009 Nov; 23(11):2102-8. PubMed ID: 19626047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.
    Lin L; Benson DM; DeAngelis S; Bakan CE; Li PK; Li C; Lin J
    Int J Cancer; 2012 Mar; 130(6):1459-69. PubMed ID: 21520044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells.
    Yang J; Cai X; Lu W; Hu C; Xu X; Yu Q; Cao P
    Cancer Lett; 2013 Jan; 328(2):243-51. PubMed ID: 23032719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS.
    Kurdi M; Booz GW
    J Cell Physiol; 2007 Aug; 212(2):424-31. PubMed ID: 17385713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
    Lu S; Gao Y; Huang X; Wang X
    Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of GP130/STAT3 and EMT by combined bazedoxifene and paclitaxel treatment in ovarian cancer.
    Park SA; Kim LK; Park HM; Kim HJ; Heo TH
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells.
    Xiao H; Bid HK; Jou D; Wu X; Yu W; Li C; Houghton PJ; Lin J
    J Biol Chem; 2015 Feb; 290(6):3418-29. PubMed ID: 25313399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.
    Lin L; Hutzen B; Li PK; Ball S; Zuo M; DeAngelis S; Foust E; Sobo M; Friedman L; Bhasin D; Cen L; Li C; Lin J
    Neoplasia; 2010 Jan; 12(1):39-50. PubMed ID: 20072652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration.
    Michaud-Levesque J; Bousquet-Gagnon N; Béliveau R
    Exp Cell Res; 2012 May; 318(8):925-35. PubMed ID: 22394507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis.
    Fischer P; Hilfiker-Kleiner D
    Basic Res Cardiol; 2007 Jul; 102(4):279-97. PubMed ID: 17530315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy.
    Zhang W; Guo J; Li S; Ma T; Xu D; Han C; Liu F; Yu W; Kong L
    Sci Rep; 2017 Apr; 7():46352. PubMed ID: 28397855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of bazedoxifene analogues targeting glycoprotein 130.
    Song D; Yu W; Ren Y; Zhu J; Wan C; Cai G; Guo J; Zhang W; Kong L
    Eur J Med Chem; 2020 Aug; 199():112375. PubMed ID: 32388278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice.
    Ruwanpura SM; McLeod L; Miller A; Jones J; Vlahos R; Ramm G; Longano A; Bardin PG; Bozinovski S; Anderson GP; Jenkins BJ
    Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(7):L627-39. PubMed ID: 22268122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells.
    Kim MJ; Nam HJ; Kim HP; Han SW; Im SA; Kim TY; Oh DY; Bang YJ
    Cancer Lett; 2013 Jul; 335(1):145-52. PubMed ID: 23402820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
    Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
    J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity.
    Wu J; Guo W; Lin SZ; Wang ZJ; Kan JT; Chen SY; Zhu YZ
    Cell Death Dis; 2016 Aug; 7(8):e2339. PubMed ID: 27537522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.